Evidence of increased microvessel density and activation of the hypoxia pathway in tumours from the hereditary leiomyomatosis and renal cell cancer syndrome - PubMed (original) (raw)
Evidence of increased microvessel density and activation of the hypoxia pathway in tumours from the hereditary leiomyomatosis and renal cell cancer syndrome
Patrick Pollard et al. J Pathol. 2005 Jan.
Abstract
The Mendelian tumour syndromes hereditary leiomyomatosis and renal cell cancer (HLRCC) and hereditary paragangliomatosis with phaeochromocytomas (HPGL) result from mutations in nuclear genes (FH and SDHB/C/D, respectively) that encode Krebs cycle enzymes. HPGL tumours are highly vascular and there is evidence that inactivation of SDH leads to activation of the hypoxia/angiogenesis pathway. In contrast, uterine leiomyomas are not generally regarded as particularly vascular lesions. In order to test the possibility that activation of the hypoxia/angiogenesis pathway contributes to tumourigenesis in HLRCC, increased vascularity and hypoxia pathway activation were searched for in HLRCC tumours. Microvessel density was markedly higher in uterine leiomyomas from HLRCC than in the surrounding myometrium; it was notable that sporadic uterine leiomyomas were actually less vascular than normal myometrium. In HLRCC tumours, there was increased expression of transcripts from the hypoxia-responsive genes vascular endothelial growth factor (VEGF) and BNIP3; sporadic uterine leiomyomas did not show these changes. All uterine leiomyomas showed decreased expression of thrombospondin 1. Although sporadic and HLRCC uterine leiomyomas appear to have identical morphology, their pathways of tumourigenesis may be fundamentally different. As is the case in HPGL, it is probable that failure of the Krebs cycle in HLRCC tumours causes inappropriate signalling that the cell is in a hypoxic state, leading to angiogenesis and perhaps directly to clonal expansion and tumour growth through some uncharacterized, cell-autonomous effect.
Similar articles
- Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome.
Sanz-Ortega J, Vocke C, Stratton P, Linehan WM, Merino MJ. Sanz-Ortega J, et al. Am J Surg Pathol. 2013 Jan;37(1):74-80. doi: 10.1097/PAS.0b013e31825ec16f. Am J Surg Pathol. 2013. PMID: 23211287 Free PMC article. - Aberrant expression of apoptosis proteins and ultrastructural aberrations in uterine leiomyomas from patients with hereditary leiomyomatosis and renal cell carcinoma.
Wortham NC, Alam NA, Barclay E, Pollard PJ, Wagner BE, Manek S, Elia G, Tomlinson IP. Wortham NC, et al. Fertil Steril. 2006 Oct;86(4):961-71. doi: 10.1016/j.fertnstert.2006.02.106. Epub 2006 Sep 7. Fertil Steril. 2006. PMID: 16962107 - Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer.
Grubb RL 3rd, Franks ME, Toro J, Middelton L, Choyke L, Fowler S, Torres-Cabala C, Glenn GM, Choyke P, Merino MJ, Zbar B, Pinto PA, Srinivasan R, Coleman JA, Linehan WM. Grubb RL 3rd, et al. J Urol. 2007 Jun;177(6):2074-9; discussion 2079-80. doi: 10.1016/j.juro.2007.01.155. J Urol. 2007. PMID: 17509289 - Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer.
Alam NA, Olpin S, Leigh IM. Alam NA, et al. Br J Dermatol. 2005 Jul;153(1):11-7. doi: 10.1111/j.1365-2133.2005.06678.x. Br J Dermatol. 2005. PMID: 16029320 Review. - [From gene to disease; cutaneous leiomyomatosis].
Badeloe S, van Geel M, van Steensel MA, Steijlen PM, Poblete-Gutiérrez P, Frank JA. Badeloe S, et al. Ned Tijdschr Geneeskd. 2007 Feb 3;151(5):300-4. Ned Tijdschr Geneeskd. 2007. PMID: 17326474 Review. Dutch.
Cited by
- Case report: Ultrasonographic findings of retroperitoneum and abdominal wall metastases of renal cell carcinoma with FH gene deletion.
Zhang X, Zhang Y, Li Y, Shen P, Liu Z, Zeng H, Zhang M, Chen N, Yao J, Huang R, Cai D. Zhang X, et al. Front Oncol. 2022 Oct 18;12:896477. doi: 10.3389/fonc.2022.896477. eCollection 2022. Front Oncol. 2022. PMID: 36330469 Free PMC article. - Increased risk of cancer in patients with fumarate hydratase germline mutation.
Lehtonen HJ, Kiuru M, Ylisaukko-Oja SK, Salovaara R, Herva R, Koivisto PA, Vierimaa O, Aittomäki K, Pukkala E, Launonen V, Aaltonen LA. Lehtonen HJ, et al. J Med Genet. 2006 Jun;43(6):523-6. doi: 10.1136/jmg.2005.036400. Epub 2005 Sep 9. J Med Genet. 2006. PMID: 16155190 Free PMC article. - Natural product-derived small molecule activators of hypoxia-inducible factor-1 (HIF-1).
Nagle DG, Zhou YD. Nagle DG, et al. Curr Pharm Des. 2006;12(21):2673-88. doi: 10.2174/138161206777698783. Curr Pharm Des. 2006. PMID: 16842166 Free PMC article. Review. - Induction of carbonic anhydrase IX by hypoxia and chemical disruption of oxygen sensing in rat fibroblasts and cardiomyocytes.
Holotnakova T, Ziegelhoffer A, Ohradanova A, Hulikova A, Novakova M, Kopacek J, Pastorek J, Pastorekova S. Holotnakova T, et al. Pflugers Arch. 2008 May;456(2):323-37. doi: 10.1007/s00424-007-0400-6. Epub 2007 Dec 11. Pflugers Arch. 2008. PMID: 18071747 - Fumarate hydratase (FH) and cancer: a paradigm of oncometabolism.
Valcarcel-Jimenez L, Frezza C. Valcarcel-Jimenez L, et al. Br J Cancer. 2023 Nov;129(10):1546-1557. doi: 10.1038/s41416-023-02412-w. Epub 2023 Sep 9. Br J Cancer. 2023. PMID: 37689804 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous